Spotty insurance coverage for GLP-1 drugs gets worse

NPR | By Sydney Lupkin

Published April 15, 2026 at 5:39 PM EDT

Insurance coverage of blockbuster obesity drugs has been spotty at best over the years, and it looks like things are getting worse, not better. Plans are dropping coverage or restricting it further.

Sydney Lupkin

Sydney Lupkin is the pharmaceuticals correspondent for NPR.

See stories by Sydney Lupkin

Support nonprofit, fact-based public service journalism

WEKU depends on support from those who view and listen to our content. There's no paywall here. Please support WEKU with your donation.

Contribute now

Related Content

The Commonwealth

Kentucky Senate censures Supreme Court justice for ‘intemperate remarks’

Sylvia Goodman

The Kentucky Senate has voted to censure a Kentucky Supreme Court justice for a judicial opinion, and called for an investigation.
NPR News

Whiting Foundation names its 10 emerging authors of 2026

Ivy Buck

The annual Whiting Award for Emerging Writers comes with $50,000 to support each winner's work. It's one of the largest prizes granted to promising new authors.
The authority of age vs. the buzziness of youth, in 'The Take'

Ailsa Chang, Kathryn Fink, Patrick Jarenwattananon, Courtney Dorning

In The Take, an older woman and a younger woman agree to exchange 10 years of their lives through a blood transfusion. NPR's Ailsa Chang speaks with author Kelly Yang.
One man's mission to clean up South Florida's mangrove forests

Catherine Welch

Picking up trash in Mangrove forests has become a calling for one Florida man.
Abandoned allies: Syria's Kurds face an uncertain future

Jane Arraf

Syrian Kurds ran their own region for 12 years after breaking away from Assad control. Now they are forced to give up autonomy. NPR visited the changing region.